Vedic Lifesciences (Redwood Shores, CA) is extending its free clinical trial design consultations on dietary supplements and functional food products to one additional quarter.
Vedic Lifesciences (Redwood Shores, CA) is extending its free clinical trial design consultations on dietary supplements and functional food products to one additional quarter.
Through its nutritional research assistance program, the company will provide free clinical trial designs and feasibility studies for any two supplements or functional food products with the intent to substantiate a client’s proposed claim statement. Vedic Lifesciences will design a small human study to be used in publications and/or submission to regulatory authorities. All human data is said to be compliant with international standards and Good Clinical Practices (GCP).
After free consultation, decision to continue with studies is optional.
Vedic Lifesciences is currently conducting four multi-center studies with a single company regarding claims relating to human growth hormone and sexual enhancement. The Canadian client was able to substantiate FTC and Health Canada label claims for a branded dietary supplement following previous work with Vedic Lifesciences.
Visit Vedic Lifesciences for more information on clinical trial designs for dietary supplements and health foods.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.